In the News
Patients may respond differently to different hypertension drug classes
The authors of a randomized, double-blind, repeated crossover trial in Sweden estimated that personalized antihypertensive therapy could yield an average reduction in systolic blood pressure of 4.4 mm Hg compared to fixed-choice therapy.
Studies look at effectiveness of bivalent booster, fluvoxamine plus inhaled budesonide for COVID-19
After four weeks, bivalent booster vaccines were 47.5% effective against hospitalization or death from COVID-19, a study in North Carolina found, while a Brazilian trial showed that fluvoxamine plus inhaled budesonide significantly reduced the risk of progression to severe disease among high-risk patients with symptomatic COVID-19.
MKSAP Quiz: Increased frequency of long-term headaches
This week's quiz asks readers to determine the most appropriate next step in treatment for a 48-year-old man with a 25-year history of headaches that have become increasingly frequent.
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
This Earth Day, learn about ACP's efforts to protect the planet
Among other initiatives, ACP has been working to educate our members and other physicians about the harm that climate change poses for human health.
Register now for ACP's live, virtual POCUS Mentorship Program
The program gives internal medicine physicians a chance to perfect POCUS skills through ongoing live, virtual expert-guided scanning sessions.
And the winner is …
ACP Internist Weekly has tallied the voting from its latest cartoon contest, where readers are invited to match wits against their peers to provide the most original and amusing caption.